Overview

Treatment of ARDS With Instilled T3

Status:
Recruiting

Trial end date:
2023-10-10

Target enrollment:

Participant gender:

Summary

It is hypothesized that instillation of (T3) into the airspace will increase alveolar fluid clearance in patients with ARDS, resulting in reduced extravascular lung water (EVLW).

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

University of Minnesota
University of Minnesota - Clinical and Translational Science Institute